Vilin Bio Med Ltd

Vilin Bio Med Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vilin Bio Med Ltd

₹ 29.0 1.94%
18 Jun - close price
Company website NSE - SME: VILINBIO
About

Incorporated in 2005, Vilin Bio Med Ltd is in the business of manufacturing and selling of pharmaceutical products[1]

Key Points

Business Overview:[1][2]
VBML is an ISO-9001-2008 & GMP certified manufacturer of Pharmaceutical formulations' viz. Oral Liquid (Syrups/Suspensions/Dry Powders (βeta & Non βeta-Lactam), Tablets & Capsules (βeta & Non βeta-Lactam), External Preparations, etc. It sells its products in bulk to Pharmaceuticals Manufacturers, Marketers and Traders. Company does not sell products under any brand name

Website NSE - ST
  • Market Cap ₹ 40.4 Cr.
  • Current Price ₹ 29.0
  • High / Low ₹ 32.5 / 15.4
  • Stock P/E 184
  • Book Value ₹ 16.5
  • Dividend Yield 0.00 %
  • ROCE 4.20 %
  • ROE 0.96 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -2.28% over past five years.
  • Company has a low return on equity of 3.34% over last 3 years.
  • Earnings include an other income of Rs.0.47 Cr.
  • Company has high debtors of 156 days.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
4.95 4.10 8.21 7.65 8.16 4.49 10.32
4.56 2.99 6.74 6.26 8.73 4.07 9.95
Operating Profit 0.39 1.11 1.47 1.39 -0.57 0.42 0.37
OPM % 7.88% 27.07% 17.90% 18.17% -6.99% 9.35% 3.59%
0.00 0.00 0.02 0.11 0.22 0.22 0.25
Interest 0.25 0.32 0.33 0.38 0.41 0.41 0.44
Depreciation 0.11 0.08 0.08 0.08 0.05 0.07 0.03
Profit before tax 0.03 0.71 1.08 1.04 -0.81 0.16 0.15
Tax % 33.33% 21.13% 35.19% 25.96% -25.93% 18.75% 33.33%
0.02 0.55 0.69 0.77 -0.61 0.12 0.10
EPS in Rs 0.06 1.67 0.69 0.55 -0.44 0.09 0.07
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
16.62 11.54 11.21 12.31 15.80 14.81
15.71 10.68 10.44 9.73 14.97 14.02
Operating Profit 0.91 0.86 0.77 2.58 0.83 0.79
OPM % 5.48% 7.45% 6.87% 20.96% 5.25% 5.33%
0.01 0.00 0.00 0.02 0.32 0.47
Interest 0.41 0.44 0.51 0.65 0.79 0.85
Depreciation 0.31 0.26 0.22 0.17 0.13 0.10
Profit before tax 0.20 0.16 0.04 1.78 0.23 0.31
Tax % 20.00% 25.00% 25.00% 30.34% 26.09% 25.81%
0.16 0.12 0.03 1.25 0.16 0.22
EPS in Rs 0.48 0.36 0.09 1.26 0.11 0.16
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: -2%
3 Years: 10%
TTM: -6%
Compounded Profit Growth
10 Years: %
5 Years: 7%
3 Years: 94%
TTM: 38%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 45%
Return on Equity
10 Years: %
5 Years: 3%
3 Years: 3%
Last Year: 1%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3.30 3.30 3.30 9.95 13.95 13.95
Reserves 3.94 4.06 4.10 0.73 8.89 9.11
4.53 5.52 5.30 4.93 6.83 2.57
2.24 1.01 0.86 2.07 2.73 2.10
Total Liabilities 14.01 13.89 13.56 17.68 32.40 27.73
2.13 1.87 1.65 1.51 1.38 1.28
CWIP 0.00 0.00 0.00 0.00 0.00 1.57
Investments 0.00 0.00 0.00 0.00 0.00 0.00
11.88 12.02 11.91 16.17 31.02 24.88
Total Assets 14.01 13.89 13.56 17.68 32.40 27.73

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-1.46 -1.00 0.21 -1.66 -5.30 -3.83
-0.02 0.00 0.00 -0.03 0.32 -1.11
1.51 0.98 -0.22 1.68 10.99 -1.05
Net Cash Flow 0.03 -0.02 -0.01 0.00 6.01 -5.99

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 159.66 241.96 253.64 166.04 131.22 155.51
Inventory Days 56.13 83.17 93.82 44.74 125.41 119.50
Days Payable 49.48 33.11 26.34 60.49 54.71 37.67
Cash Conversion Cycle 166.31 292.03 321.13 150.28 201.91 237.35
Working Capital Days 210.39 346.66 360.44 178.50 229.16 258.78
ROCE % 4.87% 4.30% 17.17% 4.51% 4.20%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Mar 2024Sep 2024Mar 2025
90.45% 64.52% 64.52% 64.09% 63.89%
9.55% 35.48% 35.48% 35.91% 36.11%
No. of Shareholders 21659585581551

Documents

Announcements

Annual reports